Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Thienyl pyrimidine derivatives with PrP(Sc) oligomer-inducing activity are a promising tool to study prions.
Curr Top Med Chem. 2013;13(19):2477-83. doi: 10.2174/15680266113136660174.
Curr Top Med Chem. 2013.
PMID: 24059332
Review.
Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity.
Ayrolles-Torro A, Imberdis T, Torrent J, Toupet K, Baskakov IV, Poncet-Montange G, Grégoire C, Roquet-Baneres F, Lehmann S, Rognan D, Pugnière M, Verdier JM, Perrier V.
Ayrolles-Torro A, et al.
J Neurosci. 2011 Oct 19;31(42):14882-92. doi: 10.1523/JNEUROSCI.0547-11.2011.
J Neurosci. 2011.
PMID: 22016521
Free PMC article.
Item in Clipboard
A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases.
Imberdis T, Ayrolles-Torro A, Duarte Rodrigues A, Torrent J, Alvarez-Martinez MT, Kovacs GG, Verdier JM, Robitzer M, Perrier V.
Imberdis T, et al. Among authors: ayrolles torro a.
Mol Neurodegener. 2016 Jan 26;11:11. doi: 10.1186/s13024-016-0074-7.
Mol Neurodegener. 2016.
PMID: 26809712
Free PMC article.
Item in Clipboard
Antibody targeting of claudin-1 as a potential colorectal cancer therapy.
Cherradi S, Ayrolles-Torro A, Vezzo-Vié N, Gueguinou N, Denis V, Combes E, Boissière F, Busson M, Canterel-Thouennon L, Mollevi C, Pugnière M, Bibeau F, Ychou M, Martineau P, Gongora C, Del Rio M.
Cherradi S, et al. Among authors: ayrolles torro a.
J Exp Clin Cancer Res. 2017 Jun 28;36(1):89. doi: 10.1186/s13046-017-0558-5.
J Exp Clin Cancer Res. 2017.
PMID: 28659146
Free PMC article.
Item in Clipboard
FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer.
Marzi L, Combes E, Vié N, Ayrolles-Torro A, Tosi D, Desigaud D, Perez-Gracia E, Larbouret C, Montagut C, Iglesias M, Jarlier M, Denis V, Linares LK, Lam EW, Martineau P, Del Rio M, Gongora C.
Marzi L, et al. Among authors: ayrolles torro a.
Br J Cancer. 2016 Nov 8;115(10):1223-1233. doi: 10.1038/bjc.2016.313. Epub 2016 Sep 29.
Br J Cancer. 2016.
PMID: 27685445
Free PMC article.
Item in Clipboard
Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells.
Cherradi S, Garambois V, Marines J, Andrade AF, Fauvre A, Morand O, Fargal M, Mancouri F, Ayrolles-Torro A, Vezzo-Vié N, Jarlier M, Loussaint G, Huvelle S, Joubert N, Mazard T, Gongora C, Pourquier P, Boissière-Michot F, Rio MD.
Cherradi S, et al. Among authors: ayrolles torro a.
Cell Biosci. 2023 Apr 11;13(1):72. doi: 10.1186/s13578-023-01015-5.
Cell Biosci. 2023.
PMID: 37041570
Free PMC article.
Item in Clipboard
Cite
Cite